ES2582283T3 - Dispositivo médico que comprende aglomerados de nanopartículas magnéticas recubiertas con alcoxisilano - Google Patents
Dispositivo médico que comprende aglomerados de nanopartículas magnéticas recubiertas con alcoxisilanoInfo
- Publication number
- ES2582283T3 ES2582283T3 ES12748166.1T ES12748166T ES2582283T3 ES 2582283 T3 ES2582283 T3 ES 2582283T3 ES 12748166 T ES12748166 T ES 12748166T ES 2582283 T3 ES2582283 T3 ES 2582283T3
- Authority
- ES
- Spain
- Prior art keywords
- alkoxysilane
- agglomerates
- medical device
- nanoparticles coated
- magnetic nanoparticles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/695—Silicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5192—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01F—MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
- H01F1/00—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01F—MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
- H01F1/00—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties
- H01F1/0036—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties showing low dimensional magnetism, i.e. spin rearrangements due to a restriction of dimensions, e.g. showing giant magnetoresistivity
- H01F1/0045—Zero dimensional, e.g. nanoparticles, soft nanoparticles for medical/biological use
- H01F1/0054—Coated nanoparticles, e.g. nanoparticles coated with organic surfactant
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01F—MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
- H01F41/00—Apparatus or processes specially adapted for manufacturing or assembling magnets, inductances or transformers; Apparatus or processes specially adapted for manufacturing materials characterised by their magnetic properties
- H01F41/14—Apparatus or processes specially adapted for manufacturing or assembling magnets, inductances or transformers; Apparatus or processes specially adapted for manufacturing materials characterised by their magnetic properties for applying magnetic films to substrates
- H01F41/16—Apparatus or processes specially adapted for manufacturing or assembling magnets, inductances or transformers; Apparatus or processes specially adapted for manufacturing materials characterised by their magnetic properties for applying magnetic films to substrates the magnetic material being applied in the form of particles, e.g. by serigraphy, to form thick magnetic films or precursors therefor
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nanotechnology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Power Engineering (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Manufacturing & Machinery (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compounds Of Iron (AREA)
- Soft Magnetic Materials (AREA)
- Hard Magnetic Materials (AREA)
- Manufacture Of Metal Powder And Suspensions Thereof (AREA)
- Powder Metallurgy (AREA)
- Electrotherapy Devices (AREA)
Abstract
Un dispositivo médico que comprende una suspensión de aglomerados de nanopartículas de metal magnético recubiertas con alcoxisilano, en donde una suspensión acuosa de nanopartículas de metal magnético se incuba con alcoxisilano, caracterizado porque la incubación se realiza esencialmente en ausencia de un solvente orgánico añadido, el alcoxisilano es trialcoxisilano y se añaden 0,3 a 0,6 x 10-3 mol de trialcoxisilano por 0,9 mol de metal.
Description
Una suspensión 2 M de nanopartículas de óxido de hierro magnético fabricada de acuerdo con el Ejemplo 1 ha sido analizada por TEM. La micrografía resultante se muestra en la Figura 1. En la micrografía, se pueden ver grandes aglomerados de nanopartículas (una nanopartícula individual indicada por una flecha). No se pueden observar nanopartículas individuales dentro del área representada -todas las nanopartículas están unidas entre sí.
7. Especificaciones de la suspensión
Una serie de producción de acuerdo con el ejemplo 1 conduce a las especificaciones físicas/químicas como se muestran en la Tabla 2.
Tabla 2: Especificaciones de una carga representativa
- AS1
- AS4 AS5
- Tamaño de la partícula (promedio z)
- 89 nm 179,6 180,8 nm
- Potencial zeta
- 53,5 mV 47,8 mV 42,5 mV
- Conductividad (25 °C)
- 2,16 ms/cm 0,90 ms/cm -
- pH (25 °C)
- 5,28 4,38 --
- Osmolalidad
- 0,03 Osmol/kg 0,08 Osmol/kg --
- SAR (a 100 kHz, a intensidad del campo dada)
- 10 W/g Fe (7,5 kA/m) 14 W/g Fe (4 kA/m) 12 W/g Fe (6 kA/m)
- Contenido del metal total (Fe)
- 15% por peso 18% por peso --
- Concentración (Fe)
- 1,99 mol/l 1,70 mol/l 1,88 mol/l
- 10 8. Reometría de rotación/Medición de la viscosidad
La viscosidad de las muestras de nanopartículas se determinó por servicios de caracterización de materiales Malvern usando reometría de rotación a 20 °C, en donde la viscosidad de cizallamiento (en Pa.s) se determinó en dependencia de la velocidad de cizallamiento (de 7 a 1500/s). Los resultados para preparaciones de nanopartículas de acuerdo con el Ejemplo 1 se muestran en la Figura 2.
- 15 9. Formación de depósitos de fluidos magnéticos in vivo
Se inyectaron 1x106 células tumorales de la línea celular de carcinoma mamario C3H RSI en la extremidad posterior derecha de los ratones de la cepa C3H-HeN (Harlan Laboratories, Borchen). Una vez que los tumores inducidos tenían un volumen de 0,57-0,85 cm3, los animales fueron asignados al azar (15 animales por grupo) y los tumores de la extremidad posterior derecha fueron inyectados con el fluido magnético del Ejemplo 1 que tiene una concentración
20 de Fe de 112 o 335 mg/ml. El contenido exacto del volumen de inyección se determinó pesando la jeringa de inyección antes y después de la inyección y calculando la diferencia (en promedio, 31 µl ± 5,8 µl).
El contenido de Fe total de tejido/tumor de los ratones se determinó después de 0 o 7 días de medición UV-vis a 565 nm utilizando la prueba de Spektroquant 14761 (Merck, Darmstadt) y un Cary 50 (Agilent Technologies, Santa Clara, Ca, USA) y un espectrómetro Tecan Infinite M 200 (Tecan Group Ltd, Männedorf, Suiza). El contenido de Fe
25 aplicado inicialmente se determinó restando del contenido de Fe total del contenido del tejido/tumor inicial del tejido (determinado midiendo el contenido de Fe de la pata izquierda no inoculada) y la pérdida de fluido magnético durante la inoculación, que fue absorbida por el hisopo utilizado. La recuperación de Fe (promedio de 15 tumores por grupo) se calculó como el contenido total de Fe, dividido por el contenido de Fe aplicado inicialmente.
13
Thiesen, B. and A. Jordan (2008). Int J Hyperthermia. 24(6): 467-74. Waldoefher, N. and K. Stief (201 1). Magnetic Transducers. US 201 1/0052609.
16
Claims (1)
-
imagen1 imagen2
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161522217P | 2011-08-10 | 2011-08-10 | |
US201161522217P | 2011-08-10 | ||
PCT/EP2012/003381 WO2013020701A2 (en) | 2011-08-10 | 2012-08-07 | Agglomerating magnetic alkoxysilane-coated nanoparticles |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2582283T3 true ES2582283T3 (es) | 2016-09-12 |
Family
ID=46690467
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES16000350T Active ES2807209T3 (es) | 2011-08-10 | 2012-08-07 | Método para fabricar nanopartículas magnéticas aglomerantes recubiertas con alcoxisilano |
ES12748166.1T Active ES2582283T3 (es) | 2011-08-10 | 2012-08-07 | Dispositivo médico que comprende aglomerados de nanopartículas magnéticas recubiertas con alcoxisilano |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES16000350T Active ES2807209T3 (es) | 2011-08-10 | 2012-08-07 | Método para fabricar nanopartículas magnéticas aglomerantes recubiertas con alcoxisilano |
Country Status (21)
Country | Link |
---|---|
US (2) | US9408912B2 (es) |
EP (2) | EP2742515B1 (es) |
JP (1) | JP5844902B2 (es) |
KR (1) | KR101513841B1 (es) |
CN (1) | CN104620334B (es) |
AU (1) | AU2012292554B2 (es) |
BR (1) | BR112014002726A8 (es) |
CA (1) | CA2844774C (es) |
CL (1) | CL2014000298A1 (es) |
CO (1) | CO6940414A2 (es) |
DE (1) | DE202012012795U1 (es) |
DK (1) | DK2742515T3 (es) |
ES (2) | ES2807209T3 (es) |
HK (1) | HK1210317A1 (es) |
IL (1) | IL230799A (es) |
MX (1) | MX358576B (es) |
PL (2) | PL2742515T3 (es) |
PT (1) | PT2742515T (es) |
RU (1) | RU2622025C2 (es) |
WO (1) | WO2013020701A2 (es) |
ZA (1) | ZA201400564B (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015188190A1 (en) * | 2014-06-06 | 2015-12-10 | The Regents Of The University Of California | Sunlight reflecting materials and methods of fabrication |
KR20220133893A (ko) | 2020-01-31 | 2022-10-05 | 매그포스 아게 | 자성 알콕시실란-코팅된 금속 함유 나노입자를 포함하는 페이스트 |
DE102020116859A1 (de) | 2020-06-26 | 2021-12-30 | Pharma Development Holding Gmbh | Liposomen |
KR102503870B1 (ko) * | 2021-01-08 | 2023-02-24 | 한밭대학교 산학협력단 | 온열치료용 산화철 나노 클러스터 및 이의 제조 방법 |
Family Cites Families (85)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3945945A (en) | 1971-05-10 | 1976-03-23 | Norton Company | High surface area alumina bodies |
US4169912A (en) | 1975-10-02 | 1979-10-02 | Dynamit Nobel Aktiengesellschaft | Iron oxide magnetic pigments for the production of magnetic coatings |
DE2543962A1 (de) | 1975-10-02 | 1977-04-14 | Dynamit Nobel Ag | Verbesserte eisenoxid-magnetpigmente fuer die herstellung von magnetschichten |
CA1254238A (en) | 1985-04-30 | 1989-05-16 | Alvin P. Gerk | Process for durable sol-gel produced alumina-based ceramics, abrasive grain and abrasive products |
US5597531A (en) * | 1985-10-04 | 1997-01-28 | Immunivest Corporation | Resuspendable coated magnetic particles and stable magnetic particle suspensions |
US4827945A (en) | 1986-07-03 | 1989-05-09 | Advanced Magnetics, Incorporated | Biologically degradable superparamagnetic materials for use in clinical applications |
FR2618084B1 (fr) | 1987-07-15 | 1989-11-10 | Rhone Poulenc Chimie | Microspheres magnetisables a base de polysiloxane, leur procede de preparation et leur application en biologie |
EP0381742B1 (en) | 1988-08-04 | 1996-06-19 | Advanced Magnetics Incorporated | Receptor mediated endocytosis type mri contrast agents |
EP0451152B1 (en) | 1988-10-13 | 1993-08-25 | Tioxide Specialties Limited | Ceramic powders |
US5460831A (en) | 1990-06-22 | 1995-10-24 | The Regents Of The University Of California | Targeted transfection nanoparticles |
US5462751A (en) | 1990-06-22 | 1995-10-31 | The Regeants Of The University Of California | Biological and pharmaceutical agents having a nanomeric biodegradable core |
DE4026978A1 (de) | 1990-08-25 | 1992-02-27 | Bayer Ag | Auf traegern angebrachte ein- oder mehrlagige schichtelemente und ihre herstellung |
US5616311A (en) | 1991-01-15 | 1997-04-01 | Hemosphere, Inc. | Non-crosslinked protein particles for therapeutic and diagnostic use |
JP3389611B2 (ja) | 1992-02-28 | 2003-03-24 | 戸田工業株式会社 | 無機物粒子含有樹脂複合球状物粉体 |
DE4212633A1 (de) | 1992-04-15 | 1993-10-21 | Inst Neue Mat Gemein Gmbh | Verfahren zur Herstellung oberflächenmodifizierter nanoskaliger keramischer Pulver |
WO1993024076A1 (en) | 1992-05-29 | 1993-12-09 | The Regents Of The University Of California | Coated transplant and method for making same |
KR0157280B1 (ko) | 1992-11-06 | 1998-11-16 | 나까토미 히로타카 | 하부소화관 방출성의 경구의약제제 |
US5401313A (en) | 1993-02-10 | 1995-03-28 | Harcros Pigments, Inc. | Surface modified particles and method of making the same |
JPH08508721A (ja) | 1993-03-17 | 1996-09-17 | シリカゲル ゲス.エム.ビー.エイチ | 超常磁性粒子、その製法及びその用途 |
JPH06270155A (ja) | 1993-03-23 | 1994-09-27 | Sekisui Chem Co Ltd | 型内被覆用樹脂組成物 |
US5547748A (en) | 1994-01-14 | 1996-08-20 | Sri International | Carbon nanoencapsulates |
FR2721615A1 (fr) | 1994-06-24 | 1995-12-29 | Rhone Poulenc Chimie | Procédé de préparation de particules d'oxyde métallique organophiles. |
ATE176077T1 (de) | 1994-07-07 | 1999-02-15 | Chiron Diagnostics Corp | Hochdispergierte magnetische metalloxidteilchen,produktionsverfahren und anwendung |
JP3436760B2 (ja) | 1994-07-27 | 2003-08-18 | ハーバート ピルグリム | 超常磁性粒子 |
US6103379A (en) | 1994-10-06 | 2000-08-15 | Bar-Ilan University | Process for the preparation of microspheres and microspheres made thereby |
GB9420390D0 (en) | 1994-10-10 | 1994-11-23 | Nycomed Salutar Inc | Liposomal agents |
US5540959A (en) | 1995-02-21 | 1996-07-30 | Howard J. Greenwald | Process for preparing a coated substrate |
DE19515820A1 (de) | 1995-04-29 | 1996-10-31 | Inst Neue Mat Gemein Gmbh | Verfahren zur Herstellung schwach agglomerierter nanoskaliger Teilchen |
JPH09646A (ja) * | 1995-06-16 | 1997-01-07 | Toshiba Corp | 治療用誘導加熱装置 |
US6022500A (en) | 1995-09-27 | 2000-02-08 | The United States Of America As Represented By The Secretary Of The Army | Polymer encapsulation and polymer microsphere composites |
US5695900A (en) * | 1995-12-21 | 1997-12-09 | Colorado School Of Mines | Surface treatment of magnetic particles for use in reprographic processes |
US5922403A (en) | 1996-03-12 | 1999-07-13 | Tecle; Berhan | Method for isolating ultrafine and fine particles |
DE19612001A1 (de) | 1996-03-18 | 1997-09-25 | Silica Gel Gmbh Adsorptions Te | Superparamagnetische Teilchen mit vergrößerter R¶1¶-Relaxivität, Verfahren zur Herstellung und deren Verwendung |
DE19614136A1 (de) | 1996-04-10 | 1997-10-16 | Inst Neue Mat Gemein Gmbh | Verfahren zur Herstellung agglomeratfreier nanoskaliger Eisenoxidteilchen mit hydrolysebeständigem Überzug |
US5922537A (en) | 1996-11-08 | 1999-07-13 | N.o slashed.AB Immunoassay, Inc. | Nanoparticles biosensor |
JP3902794B2 (ja) | 1997-03-07 | 2007-04-11 | マックス−デルブルック−セントラム フュア モレクラーレ メディシン | 特異的磁気体、その製造方法及び使用 |
DE19716732C2 (de) | 1997-03-07 | 1999-03-25 | Max Delbrueck Centrum | Spezifische Magnetosomen, Verfahren zu ihrer Herstellung und ihre Verwendung |
WO1998052992A1 (de) * | 1997-05-23 | 1998-11-26 | Bayer Aktiengesellschaft | Organosilan-oligomere |
DE19726282A1 (de) | 1997-06-20 | 1998-12-24 | Inst Neue Mat Gemein Gmbh | Nanoskalige Teilchen mit einem von mindestens zwei Schalen umgebenen eisenoxid-haltigen Kern |
DE19912502A1 (de) | 1999-03-19 | 2000-09-21 | Inst Neue Mat Gemein Gmbh | Nanoskalige Teilchen, Komplexe mit Polynukleotiden und deren Verwendung |
DE19921088C2 (de) | 1999-04-30 | 2003-08-07 | Magforce Applic Gmbh | Stent zur Offenhaltung gangartiger Strukturen |
DE19940220B4 (de) | 1999-08-19 | 2007-05-03 | Magforce Nanotechnologies Ag | Medizinisches Präparat zur Behandlung von Arthrose, Arthritis und anderen rheumatischen Gelenkerkrankungen |
US6548264B1 (en) | 2000-05-17 | 2003-04-15 | University Of Florida | Coated nanoparticles |
WO2002098364A2 (en) | 2001-06-06 | 2002-12-12 | The General Hospital Corporation | Magnetic-nanoparticle conjugates and methods of use |
US7731648B2 (en) | 2001-07-25 | 2010-06-08 | Aduro Biotech | Magnetic nanoscale particle compositions, and therapeutic methods related thereto |
US20040156852A1 (en) | 2003-02-06 | 2004-08-12 | Triton Biosystems, Inc. | Therapy via targeted delivery of nanoscale particles |
DE10153639A1 (de) * | 2001-10-31 | 2003-05-22 | Inst Neue Mat Gemein Gmbh | Superparamagnetisches Eisenoxid enthaltende Kompositpartikel |
DE10261406A1 (de) | 2002-12-30 | 2004-07-15 | Sustech Gmbh & Co. Kg | Verfahren zur Herstellung oberflächenbeschichteter nanoskaliger Teilchen und von Suspensionen, die diese enthalten |
US20040156846A1 (en) | 2003-02-06 | 2004-08-12 | Triton Biosystems, Inc. | Therapy via targeted delivery of nanoscale particles using L6 antibodies |
DE10331439B3 (de) | 2003-07-10 | 2005-02-03 | Micromod Partikeltechnologie Gmbh | Magnetische Nanopartikel mit verbesserten Magneteigenschaften |
US20050119725A1 (en) | 2003-04-08 | 2005-06-02 | Xingwu Wang | Energetically controlled delivery of biologically active material from an implanted medical device |
FR2855315B1 (fr) | 2003-05-23 | 2005-08-19 | Centre Nat Rech Scient | Ferrofluides stables en milieu neutre et ferrofluides modifies obtenus par modification de la surface des particules de ces ferrofluides |
US8651113B2 (en) | 2003-06-18 | 2014-02-18 | Swr&D Inc. | Magnetically responsive nanoparticle therapeutic constructs and methods of making and using |
US7531149B2 (en) | 2003-10-14 | 2009-05-12 | The Board Of Trustees Of The University Of Arkansas | Synthetic control of metal oxide nanocrystal sizes and shapes |
US20050090732A1 (en) | 2003-10-28 | 2005-04-28 | Triton Biosystems, Inc. | Therapy via targeted delivery of nanoscale particles |
DE102004052533A1 (de) | 2004-10-15 | 2006-05-04 | Mykhaylyk, Olga, Dr. | Magnetische Partikel zur Verwendung in Therapie und Diagnostik |
WO2006057467A1 (en) | 2004-11-26 | 2006-06-01 | Seoul National University Industry Foundation | Method for large-scale production of monodisperse nanoparticles |
US7462446B2 (en) | 2005-03-18 | 2008-12-09 | University Of Washington | Magnetic nanoparticle compositions and methods |
DE102005016873A1 (de) | 2005-04-12 | 2006-10-19 | Magforce Nanotechnologies Ag | Nanopartikel-Wirstoff-Konjugate |
JP2008545665A (ja) | 2005-05-23 | 2008-12-18 | ユニベルシテ ドゥ ジュネーブ | 高体温による処置のための注入可能な超常磁性ナノ粒子および高体温インプラントを形成するための使用 |
GB0512374D0 (en) | 2005-06-17 | 2005-07-27 | Nanosphere Ltd | Coated microspheres |
DE102005039579B4 (de) * | 2005-08-19 | 2022-06-30 | Magforce Ag | Verfahren zur Einschleusung von therapeutischen Substanzen in Zellen |
US20070269380A1 (en) | 2005-10-11 | 2007-11-22 | Washington, University Of | Methotrexate-modified nanoparticles and related methods |
DE102005059751A1 (de) | 2005-12-09 | 2007-06-14 | Ferropharm Gmbh Forschungslabor | Wässrige Dispersion von superparamagnetischen Eindomänenteilchen, deren Herstellung und Verwendung zur Diagnose und Therapie |
JP2008019202A (ja) * | 2006-07-12 | 2008-01-31 | Koichi Jinbo | メラノーマ標的温熱免疫療法治療剤 |
CH697953B1 (fr) | 2006-07-31 | 2010-01-29 | Ecole Polytech | Nanoparticules à noyau métallique recouvert de silice. |
TWI321133B (en) | 2006-08-01 | 2010-03-01 | Univ Kaohsiung Medical | Folate-receptor-targeting iron oxide nanoparticles coated with poly(ethylene glycol) |
RU2373957C2 (ru) | 2006-10-13 | 2009-11-27 | Александр Метталинович Тишин | Носитель для лекарственных средств и биологически активных веществ для лечения и диагностики и применение его для создания лекарственных средств и способа регулируемой управляемой доставки лекарственного средства или биологически активного вещества с регулируемой десорбцией его |
EP1935436A1 (en) | 2006-12-12 | 2008-06-25 | Dublin City University | Nanoparticle clusters and methods for forming same |
JP5057208B2 (ja) * | 2006-12-20 | 2012-10-24 | 株式会社豊田中央研究所 | 磁性材料の製造方法 |
US20110104073A1 (en) | 2007-01-18 | 2011-05-05 | Qi Zeng | Iron/Iron Oxide Nanoparticle and Use Thereof |
EP1952919B1 (en) | 2007-02-02 | 2013-04-24 | FUJIFILM Corporation | Magnetic nanoparticles and aqueous colloid composition containing the same |
BRPI0821856A2 (pt) | 2008-01-04 | 2015-06-16 | Sparkxis B V | Modificação na superfície de nanopartículas de óxido metálico |
DE102008003615A1 (de) * | 2008-01-09 | 2009-07-16 | Magforce Nanotechnologies Ag | Magnetische Transducer |
US20100284924A1 (en) | 2008-01-23 | 2010-11-11 | The Regents Of The University Of California | Nano-devices having impellers for capture and release of molecules |
DE102008008522A1 (de) | 2008-02-11 | 2009-08-13 | Magforce Nanotechnologies Ag | Implantierbare Nanopartikel-enthaltende Produkte |
US20090226376A1 (en) | 2008-03-05 | 2009-09-10 | General Electric Company | Novel Mixed Ligand Core/Shell Iron Oxide Nanoparticles for Inflammation Imaging |
WO2010062615A1 (en) | 2008-10-27 | 2010-06-03 | Board Of Trustees Of The University Of Arkansas | Metallic nanoparticles with coated shells and applications of same |
GB2472446A (en) | 2009-08-07 | 2011-02-09 | Ct Fuer Angewandte Nanotechnologie | Metal oxide particles coated with polyethylene glycol and their synthesis |
DE102009058769A1 (de) | 2009-12-16 | 2011-06-22 | MagForce Nanotechnologies AG, 10589 | Temperaturabhängige Aktivierung von katalytischen Nukleinsäuren zur kontrollierten Wirkstofffreisetzung |
EP2383374A1 (en) | 2010-04-29 | 2011-11-02 | BASF Corporation | Nano-particles containing carbon and a ferromagnetic metal or alloy |
US8945628B2 (en) | 2010-05-26 | 2015-02-03 | The General Hospital Corporation | Magnetic nanoparticles |
JP2013529677A (ja) | 2010-06-29 | 2013-07-22 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 磁気粒子イメージング(mpi)のための高性能鉄酸化物粒子トレーサーの合成 |
TW201247225A (en) | 2011-05-17 | 2012-12-01 | Univ Nat Chiao Tung | Drug carrier with thermal sensitivity, manufacturing method thereof, and use of the same as NMR contrast agent |
US10220004B2 (en) | 2011-07-14 | 2019-03-05 | The Regents Of The University Of California | Method of controlled delivery using sub-micron-scale machines |
-
2012
- 2012-08-07 AU AU2012292554A patent/AU2012292554B2/en active Active
- 2012-08-07 PL PL12748166T patent/PL2742515T3/pl unknown
- 2012-08-07 DK DK12748166.1T patent/DK2742515T3/en active
- 2012-08-07 ES ES16000350T patent/ES2807209T3/es active Active
- 2012-08-07 EP EP12748166.1A patent/EP2742515B1/en active Active
- 2012-08-07 WO PCT/EP2012/003381 patent/WO2013020701A2/en active Application Filing
- 2012-08-07 EP EP16000350.5A patent/EP3038115B1/en active Active
- 2012-08-07 KR KR1020147005840A patent/KR101513841B1/ko active IP Right Grant
- 2012-08-07 US US13/877,891 patent/US9408912B2/en active Active
- 2012-08-07 BR BR112014002726A patent/BR112014002726A8/pt not_active IP Right Cessation
- 2012-08-07 DE DE202012012795U patent/DE202012012795U1/de not_active Expired - Lifetime
- 2012-08-07 JP JP2014524301A patent/JP5844902B2/ja active Active
- 2012-08-07 CN CN201280038864.1A patent/CN104620334B/zh active Active
- 2012-08-07 ES ES12748166.1T patent/ES2582283T3/es active Active
- 2012-08-07 CA CA2844774A patent/CA2844774C/en active Active
- 2012-08-07 RU RU2014109015A patent/RU2622025C2/ru active
- 2012-08-07 PL PL16000350T patent/PL3038115T3/pl unknown
- 2012-08-07 PT PT127481661T patent/PT2742515T/pt unknown
- 2012-08-07 MX MX2014001186A patent/MX358576B/es active IP Right Grant
-
2014
- 2014-01-23 ZA ZA2014/00564A patent/ZA201400564B/en unknown
- 2014-02-03 IL IL230799A patent/IL230799A/en active IP Right Grant
- 2014-02-06 CL CL2014000298A patent/CL2014000298A1/es unknown
- 2014-02-07 CO CO14026546A patent/CO6940414A2/es unknown
-
2015
- 2015-11-05 HK HK15110910.9A patent/HK1210317A1/zh unknown
-
2016
- 2016-06-30 US US15/198,708 patent/US9962442B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Alphandéry et al. | Development of non-pyrogenic magnetosome minerals coated with poly-l-lysine leading to full disappearance of intracranial U87-Luc glioblastoma in 100% of treated mice using magnetic hyperthermia | |
Alphandéry et al. | Preparation of chains of magnetosomes, isolated from Magnetospirillum magneticum strain AMB-1 magnetotactic bacteria, yielding efficient treatment of tumors using magnetic hyperthermia | |
Céspedes et al. | Bacterially synthesized ferrite nanoparticles for magnetic hyperthermia applications | |
Guardia et al. | Water-soluble iron oxide nanocubes with high values of specific absorption rate for cancer cell hyperthermia treatment | |
Xu et al. | An intelligent nanoplatform for imaging-guided photodynamic/photothermal/chemo-therapy based on upconversion nanoparticles and CuS integrated black phosphorus | |
Jiang et al. | Biocompatible heat-shock protein inhibitor-delivered flowerlike short-wave infrared nanoprobe for mild temperature-driven highly efficient tumor ablation | |
Patil et al. | In vitro hyperthermia with improved colloidal stability and enhanced SAR of magnetic core/shell nanostructures | |
Shi et al. | Engineered multifunctional nanocarriers for cancer diagnosis and therapeutics | |
Bai et al. | Inductive heating property of graphene oxide–Fe3O4 nanoparticles hybrid in an AC magnetic field for localized hyperthermia | |
Tian et al. | Near infrared‐triggered theranostic nanoplatform with controlled release of HSP90 inhibitor for synergistic mild photothermal and enhanced nanocatalytic therapy with hypoxia relief | |
ES2582283T3 (es) | Dispositivo médico que comprende aglomerados de nanopartículas magnéticas recubiertas con alcoxisilano | |
Chen et al. | Azo-functionalized Fe 3 O 4 nanoparticles: a near-infrared light triggered drug delivery system for combined therapy of cancer with low toxicity | |
Lin et al. | Cu (II) doped polyaniline nanoshuttles for multimodal tumor diagnosis and therapy | |
Ali et al. | Graphene oxide/zinc ferrite nanocomposite loaded with doxorubicin as a potential theranostic mediu in cancer therapy and magnetic resonance imaging | |
Zhang et al. | Magnetofluorescent photothermal micelles packaged with GdN@ CQDs as photothermal and chemical dual-modal therapeutic agents | |
Li et al. | Activatable molecular MRI nanoprobe for tumor cell imaging based on gadolinium oxide and iron oxide nanoparticle | |
Ding et al. | Redox-responsive dextran based theranostic nanoparticles for near-infrared/magnetic resonance imaging and magnetically targeted photodynamic therapy | |
CN103976956A (zh) | 一种靶向抗肝癌纳米粒子及其制备方法和应用 | |
Zheng et al. | Design of multifunctional FePt/GO nanocomposites for targeting, dual-modal imaging diagnostic and in situ therapeutic potential theranostic platform | |
Yang et al. | Activation of autophagy by in situ Zn2+ chelation reaction for enhanced tumor chemoimmunotherapy | |
Foroutan et al. | Intraperitoneal injection of graphene oxide nanoparticle accelerates stem cell therapy effects on acute kidney injury | |
Zhang et al. | Synthesis of Fe3O4/PDA nanocomposites for osteosarcoma magnetic resonance imaging and photothermal therapy | |
Periyathambi et al. | Development of water-soluble curcumin grafted magnetic nanoparticles for enhancing bioavailability, fluorescence, and magnetic resonance imaging activity | |
Yang et al. | Tumor microenvironment activated glutathione self-depletion theranostic nanocapsules for imaging-directed synergistic cancer therapy | |
Yin et al. | Intelligent gold nanoparticles for malignant tumor treatment via spontaneous copper manipulation and on-demand photothermal therapy based on copper induced click chemistry |